Inogen Inc
INGN8.790USD
+0.470+5.65%
收盘 09/18, 16:00（美东）报价延迟15分钟
237.69M总市值
亏损市盈率 TTM
关于 Inogen Inc 公司
Inogen, Inc. 是一家医疗技术公司，提供用于家庭护理的呼吸产品。该公司通过开发、制造和营销便携式氧气浓缩器来支持患者的呼吸护理，这些浓缩器用于为患有慢性呼吸系统疾病的患者提供补充性长期氧气治疗。其 Inogen One 和 Inogen Rove 系统将空气浓缩在患者周围，通过电池提供补充氧气源，可在家中、车内或有插座的公共场所插入插座。其 Inogen One 系统减少了患者对固定浓缩器和氧气压缩气罐的依赖。其 Inogen Connect 是 Inogen One G4、Inogen One G5 和 Rove 6 的无线连接平台，由供长期氧气治疗用户使用的前端移动应用程序和供家庭护理提供者使用的后端数据库门户组成。它还提供气道清除设备 Simeox。
公司简介
公司代码INGN
公司名称Inogen Inc
上市日期Feb 14, 2014
CEOMr. Kevin R. M. Smith
员工数量766
证券类型Ordinary Share
年结日Feb 14
公司地址859 Ward Drive
城市GOLETA
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编93111
电话18055620500
网址https://www.inogen.com/
公司代码INGN
上市日期Feb 14, 2014
CEOMr. Kevin R. M. Smith
公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.62K
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
Mr. Kevin P. Smith
Mr. Kevin P. Smith
Executive Vice President - Business Development, General Counsel, Secretary
Executive Vice President - Business Development, General Counsel, Secretary
--
--
Ms. Elizabeth (Beth) Mora, CPA
Ms. Elizabeth (Beth) Mora, CPA
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Kevin R. M. Smith
Mr. Kevin R. M. Smith
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Mary Katherine (Kay) Ladone
Ms. Mary Katherine (Kay) Ladone
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Kevin M. King
Mr. Kevin M. King
Independent Director
Independent Director
55.01K
+125.45%
Mr. Glenn S. Boehnlein, CPA
Mr. Glenn S. Boehnlein, CPA
Independent Director
Independent Director
55.01K
+125.45%
Mr. Michael J. Bourque
Mr. Michael J. Bourque
Chief Financial Officer, Executive Vice President, Corporate Treasurer
Chief Financial Officer, Executive Vice President, Corporate Treasurer
49.15K
+3.15%
Ms. Mira Sahney
Ms. Mira Sahney
Independent Director
Independent Director
30.61K
--
Mr. Gregoire Ramade
Mr. Gregoire Ramade
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.62K
--
Ms. Jennifer Boyer
Ms. Jennifer Boyer
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
Chief Human Resources Officer, Executive Vice President - Enterprise Enablement
--
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
暂无数据
地区USD
名称
营收
占比
U.S. revenue
50.30M
61.13%
Non-U.S. revenue
31.98M
38.87%
业务
地区
暂无数据
股东统计
更新时间: 8月19日 周二
更新时间: 8月19日 周二
持股股东
股东类型
持股股东
持股股东
占比
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.71%
The Vanguard Group, Inc.
6.12%
BlackRock Institutional Trust Company, N.A.
5.61%
Kent Lake PR LLC
3.92%
Acadian Asset Management LLC
3.76%
其他
70.87%
持股股东
持股股东
占比
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
9.71%
The Vanguard Group, Inc.
6.12%
BlackRock Institutional Trust Company, N.A.
5.61%
Kent Lake PR LLC
3.92%
Acadian Asset Management LLC
3.76%
其他
70.87%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
28.17%
Investment Advisor
25.05%
Hedge Fund
18.06%
Corporation
9.71%
Individual Investor
2.37%
Research Firm
1.83%
Family Office
0.92%
Sovereign Wealth Fund
0.41%
Pension Fund
0.34%
其他
13.13%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
330
22.77M
84.68%
-2.73M
2025Q1
372
22.71M
84.47%
-2.93M
2024Q4
375
21.79M
82.19%
-5.25M
2024Q3
367
21.78M
91.28%
-6.90M
2024Q2
360
23.19M
97.91%
-6.59M
2024Q1
364
22.78M
97.44%
-4.92M
2023Q4
369
22.26M
95.31%
-4.56M
2023Q3
386
22.05M
94.85%
-5.76M
2023Q2
403
22.24M
96.20%
-5.90M
2023Q1
403
23.45M
102.09%
-2.61M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.- 20211st Phase ESOP
2.63M
9.77%
+2.63M
--
Feb 21, 2025
The Vanguard Group, Inc.
1.54M
5.73%
+82.64K
+5.67%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.58M
5.88%
-16.61K
-1.04%
Mar 31, 2025
Kent Lake PR LLC
1.00M
3.73%
+417.04K
+71.10%
Mar 31, 2025
Acadian Asset Management LLC
1.03M
3.82%
+270.45K
+35.69%
Mar 31, 2025
Camber Capital Management LP
975.00K
3.63%
-1.02M
-51.25%
Mar 31, 2025
Columbia Threadneedle Investments (US)
874.53K
3.25%
+25.55K
+3.01%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
757.12K
2.82%
+149.28K
+24.56%
Mar 31, 2025
Renaissance Technologies LLC
730.80K
2.72%
+237.90K
+48.27%
Mar 31, 2025
查看更多
持股ETF
更新时间: 9月6日 周六
更新时间: 9月6日 周六
机构名称
占比
Cultivar ETF
0.71%
Invesco NASDAQ Future Gen 200 ETF
0.54%
Federated Hermes MDT Small Cap Core ETF
0.39%
iShares Micro-Cap ETF
0.03%
Avantis US Small Cap Equity ETF
0.02%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Value ETF
0.01%
iShares Russell 3000 ETF
0%
Cultivar ETF
占比0.71%
Invesco NASDAQ Future Gen 200 ETF
占比0.54%
Federated Hermes MDT Small Cap Core ETF
占比0.39%
iShares Micro-Cap ETF
占比0.03%
Avantis US Small Cap Equity ETF
占比0.02%
Invesco RAFI US 1500 Small-Mid ETF
占比0.02%
Global X Russell 2000 ETF
占比0.01%
iShares Russell 2000 ETF
占比0.01%
iShares Russell 2000 Value ETF
占比0.01%
iShares Russell 3000 ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
